Cisbio Bioassays Press Releases
|
Cisbio Bioassays Honored with the 2009 Frost & Sullivan North America Technology Innovation of the Year Award
Paradigm shifting Tag-lite™ technology platform recognized for GPCR drug discovery |
|
|
Cisbio Bioassays introduces Tag-lite™ Platform for the study of receptor ligand binding and dimerization
Non-radioactive, cost-effective cell surface study and screening platform reaffirms company's leading position in GPCR drug discovery research |
|
|
Cisbio Bioassays' IP-One Terbium assay enables measurement of different compound classes using single technology
Effective profiling of inverse agonists, agonists and antagonists of Gq-coupled receptors shows potential of assay kit, unique terbium-based technology |
|
|
Cisbio Bioassays selects CyBio robotic workstation to enhance custom assay development capabilities
Robust and flexible robotic workstation complements Cisbio’s expertise in creating and optimizing HTRF assays |
|
| IBA finalizes acquisition of CIS BIO international by buying out the IRE's shares | |
|
Cisbio Launches HTRF® Terbium Platform for GPCR Screening at SBS
IP-One Tb Assay is first product in second generation HTRF® pipeline |
|
| Cisbio adopts BellBrook LABS' Transcreener platform for enhanced target screening services' | |
|
Cisbio and Lumiphore Announce Partnership for New Product and Technology Development Incorporating Lumi4™ Compounds
Bagnols-sur-Cèze, France and Redwood City, CA, USA - September 5, 2007 |
|
|
Cisbio international Announces Launch of HTRF® KinEASE™TK at SBS
Company's universal kinase assay platform expanded to address Tyrosine enzymes |
|
|
Cisbio international Launches New HTRF® Cell-Based Assays
Company Expands Integration of d2 Acceptor Molecule to Assays in Inflammation and Metabolic Diseases Fields |
|
|
Cisbio international Expands List of Serine/Threonine
Company's universal kinase assay platform now validated on 104 kinases |
|
|
Cisbio International Awarded $1.9 million Research Grant By France National Research Agency
Company's Intracellular Molecular Imaging Project Selected from 400 Grant Applications Highlights R&D Initiatives |
|
|
Cisbio international Introduces IP-One ELISA at 4th Annual GPCR Congress
Company's second IP-One assay can be used by all laboratories focused on GPCR-based targets |
|
|
Cisbio international Introduces IP-One Assay for GPCR-Gq High-Throughput Screening Applications
Company's HTRF Customers Deploy Novel Screening Platform for GPCR Target Validation |
|
|
Upstate and Cisbio international Announce Launch of HTRF® KinEASE™
New kits for rapid kinase assay development mark second product collaboration between the two companies |
|
|
Cisbio international Launches New cAMP Assays at SBS
Optimization of cAMP Assay Formats with d2 Acceptor Molecule Complements IP-One Assay to Enhance GPCR Platform |
|
|
Cisbio international Introduces New cGMP
Powerful New Kit Available for Screening Both Soluble and Particulate Guanylyl Cyclases |
|
|
Cisbio international Introduces Enhanced cAMP Assay Development Kit
Company Enters into Collaboration with Euroscreen for Recombinant Cell Line Validation using HTRF® |
|
|
Cisbio international Establishes U.S. Custom Labeling and Assay Development Facility
Company Also Appoints Mark Schmeizl to Lead North American Sales and Business Development |
|
|
Cisbio International Adds to HTRF® Portfolio With Introduction of Kinase and Ubiquitin Toolboxes
Company Expands Line of High-throughput Screening Solutions |
|
|
Cisbio international Announces Strategic Collaborations With Instrumentation Measurement Systems Developers
Company Extends HTRF® Solution to Reach High Quality Readout Levels |
|
|
Cisbio Announces Collaborations With Leading Reagent Developers
Company Strengthens HTRF® Technology Base for Kinase Screening Through New Partnerships |


